Cantab Biopharmaceuticals
Cambridge · Founded 2006
About Cantab Biopharmaceuticals
Cantab Biopharmaceuticals Ltd is a drug development company focused on the development of "biosuperior" products. Based on Cambridge Science Park, Cantab is at the heart of the largest biotech cluster in Europe. Cantab is using it's extensive experience in biopharmaceutical discovery, process development and GMP manufacturing to expedite the development of biosuperiors from inception through clinical development. Previously marketed, off-patent, biologics will be enhanced by the application of appropriate cutting-edge technologies in protein expression/engineering, process/manufacturing technology, protein conjugation, formulation and drug delivery. Particular areas of drug characteristics that Cantab seek to improve upon are product presentation and stability, pharmacokinetics, pharmacodynamics, immunogenicity and drug delivery.
Company Facts
- Founded: 2006
- Legal name: Cantab Biopharmaceuticals Ltd
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.1M
- Last round: Series Unknown (Jan 2010)
- Website: cantabbio.com
- Phone: 44 1223 423 413
Social Profiles
Canonical: https://fsome.com/organization/cantab-biopharmaceuticals-8420131 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.